Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at  The European Society for Blood and Marrow Transplantation (EBMT), shared on their X/Twitter:

”Finally out. Methodological challenges in the development of endpoints for myelofibrosis clinical trials.”

Proceed to the article.
Source: Nico Gagelmann/X